SavedAdd your journal

Journals / Turkish Journal of Surgery / 2018 / Cilt: 34 - Sayı: 1

Severe decrease in SpO2 and methemoglobinemia following subareolar isosulfan blue administration and clinical relevance

Esra YÜKSEL
Dilek DUMAN
Levent YENİAY
Sezgin ULUKAYA
Pages
74–76
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present case report presentsa severe decrease in SpO2 due to methemoglobinemia following isosulfan blue administration as well as skin andurine signs and inconsistency with clinical picture in a 67-year-old, 77 kg, ASA II female case who underwent sentinellymph node biopsy under general anesthesia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The level of axillary lymph node involvement in breast cancer is a critical decision factor for adjuvant therapy andthe most important indicator of prognosis and survival.
📊
Key Findings & Data:Radiocolloid substances (Technetium-99m) and/or bluedyes such as methylene blue or isosulfan blue are used during sentinel lymph node biopsy.
💡
Conclusion & Impact:The present case report presentsa severe decrease in SpO2 due to methemoglobinemia following isosulfan blue administration as well as skin andurine signs and inconsistency with clinical picture in a 67-year-old, 77 kg, ASA II female case who underwent sentinellymph node biopsy under general anesthesia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The level of axillary lymph node involvement in breast cancer is a critical decision factor for adjuvant therapy andthe most important indicator of prognosis and survival. Sentinel lymph node biopsy is a minimally invasive techniquewith low morbidity in axillary staging of breast cancer. Radiocolloid substances (Technetium-99m) and/or bluedyes such as methylene blue or isosulfan blue are used during sentinel lymph node biopsy. Isosulfan blue stain isfrequently used in sentinel lymph node biopsy and rarely causes complications. The present case report presentsa severe decrease in SpO2 due to methemoglobinemia following isosulfan blue administration as well as skin andurine signs and inconsistency with clinical picture in a 67-year-old, 77 kg, ASA II female case who underwent sentinellymph node biopsy under general anesthesia.

🔖

Cite This Article

YÜKSEL, E., DUMAN, D., YENİAY, L., ULUKAYA, S. (2018). Severe decrease in SpO2 and methemoglobinemia following subareolar isosulfan blue administration and clinical relevance. Turkish Journal of Surgery, Cilt: 34 - Sayı: 1, 74–76. https://ajindex.com/articles/390540

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Maaskant-Braat AJ, Roumen RM, Voogd AC, Pijpers R, Luiten EJ, Rutgers EJ, et al. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol 2013; 20: 620-626. [CrossRef] Masannat Y, Shenoy H, Speirs V, Hanby A, Horgan K. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol 2006; 32: 381-384. [CrossRef] Haque RA, Wagner A, Whisken JA, Nasser SM, Ewan PW. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010; 65: 396-400. [CrossRef] Burgoyne LL, Jay DW, Bikhazi GB, De Armendi AJ. Isosulfan blue causes factitious methemoglobinemia in an infant. Pediatric Anesthesia 2005; 15: 1116-1119. [CrossRef] Hayakawa M, Morimoto Y, Kemmotsu O. Patent blue-induced false-methemoglobinemia. Masui 2000; 49: 774-776.
  2. Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J 2011; 104: 757-761. [CrossRef] Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006; 96: 497-500. [CrossRef] Cinar H, Koca B, Kesicioglu T, Karabulut K, Karabicak I, Polat C, Tur AH. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer. Breast 2012; 21: 220-222. [CrossRef] Hueter L, Schwarzkopf K, Karzai W. Interference of patent blue V dye with pulse oximetry and co-oximetry. Eur J Anaesthesiol 2005; 22: 475-476. [CrossRef] Murakami T, Kayo R, Kajita I, Cho S, Saito H. False decrease in pulse oximetry readings due to patent blue in a patient with breast cancer. Masui 2003; 52: 909-911.
  3. Lai HC, Hsu HM, Cherng CH, Lin SL, Wu CT, Yu JC, et al. Interference of patent blue dye with pulse oximetry readings, methemoglobin measurements, and blue urine in sentinel lymph node mapping: a case report and review of the literature. Acta Anaesthesiol Taiwan 2011; 49: 162-164. [CrossRef]